Asociación del índice neutrófilo-linfocito y el estadio clínico en el diagnóstico inicial de melanoma

IF 0.1 Q4 ONCOLOGY
Christian Patricio Camacho Limas , Raquel Gerson Cwilich , María del Ángel Góngora Jurado , Marcos López Naveda
{"title":"Asociación del índice neutrófilo-linfocito y el estadio clínico en el diagnóstico inicial de melanoma","authors":"Christian Patricio Camacho Limas ,&nbsp;Raquel Gerson Cwilich ,&nbsp;María del Ángel Góngora Jurado ,&nbsp;Marcos López Naveda","doi":"10.1016/j.gamo.2016.08.002","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><p>Measure and compare the neutrophil-lymphocyte ratio (NLR) with clinical stage of melanoma at diagnosis. To assess the association between NLR at initial diagnosis of melanoma and clinical stage at different stages of patients from a private cancer centre of Mexico City.</p></div><div><h3>Methods</h3><p>An observational, analytical, retrospective study was conducted on 63 patients with a melanoma diagnosis by reviewing medical records. The study included all patients diagnosed with melanoma biopsy reported in the period from 2002 to 2015.</p></div><div><h3>Results</h3><p>Of the 63 patients studied, a mean LNR of 4.1 (SD 6.44) was obtained. The median was 2.7, and a correlation of 58% was found between LNR (&gt;<!--> <!-->2.7) and the outcome of death in the subgroup of patients in clinical stage<!--> <!-->&gt;<!--> <!-->IIA.</p></div><div><h3>Conclusions</h3><p>This study shows a trend association between LNR (&gt;<!--> <!-->2.7) and clinical stage, which was not statistically significant due to the limited sample size. A single correlation was found with the subgroup of patients with advanced disease and an LNR<!--> <!-->&gt;<!--> <!-->2.7 and outcome of death, but not in the other variables (progression and recurrence). This work is objective biochemical proof that this accessible and inexpensive tool could provide prognostic information for advanced-stage melanoma.</p></div>","PeriodicalId":41581,"journal":{"name":"Gaceta Mexicana de Oncologia","volume":"15 5","pages":"Pages 268-277"},"PeriodicalIF":0.1000,"publicationDate":"2016-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.gamo.2016.08.002","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Gaceta Mexicana de Oncologia","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1665920116300761","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 2

Abstract

Objectives

Measure and compare the neutrophil-lymphocyte ratio (NLR) with clinical stage of melanoma at diagnosis. To assess the association between NLR at initial diagnosis of melanoma and clinical stage at different stages of patients from a private cancer centre of Mexico City.

Methods

An observational, analytical, retrospective study was conducted on 63 patients with a melanoma diagnosis by reviewing medical records. The study included all patients diagnosed with melanoma biopsy reported in the period from 2002 to 2015.

Results

Of the 63 patients studied, a mean LNR of 4.1 (SD 6.44) was obtained. The median was 2.7, and a correlation of 58% was found between LNR (> 2.7) and the outcome of death in the subgroup of patients in clinical stage > IIA.

Conclusions

This study shows a trend association between LNR (> 2.7) and clinical stage, which was not statistically significant due to the limited sample size. A single correlation was found with the subgroup of patients with advanced disease and an LNR > 2.7 and outcome of death, but not in the other variables (progression and recurrence). This work is objective biochemical proof that this accessible and inexpensive tool could provide prognostic information for advanced-stage melanoma.

中性粒细胞-淋巴细胞指数与黑色素瘤初始诊断临床分期的关系
目的测定和比较黑色素瘤诊断时中性粒细胞淋巴细胞比值(NLR)与临床分期的关系。评估来自墨西哥城一家私人癌症中心的不同阶段患者黑色素瘤初始诊断时NLR与临床阶段之间的关系。方法对63例诊断为黑色素瘤的患者进行观察性、分析性、回顾性研究。该研究包括2002年至2015年期间报告的所有被诊断为黑色素瘤活检的患者。结果63例患者的平均LNR为4.1 (SD 6.44)。中位数为2.7,LNR (>2.7)和临床分期>亚组患者的死亡结局;花絮。结论本研究显示LNR (>2.7)和临床分期,由于样本量有限,差异无统计学意义。发现晚期疾病患者亚组和LNR >患者之间存在单一相关性;2.7和死亡结局,但在其他变量(进展和复发)中没有。这项工作是客观的生化证据,证明这种易于获得和廉价的工具可以为晚期黑色素瘤提供预后信息。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
0.10
自引率
0.00%
发文量
255
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信